The Department of Justice and Health and Human Services recently conceded a case, which was supposed to be the first Autism Omnibus Test Case, until the government agencies decided that the ingredient of thimerosal did not cause autism in Hannah Poling, but a rare mitochondria disorder, which then contributed to autism-like symptoms. Kirby claims that if the findings were so rare, why was the next test case taken out of Vaccine Court because of similarities to Poling’s condition?
He writes: The boy who was selected to replace Hannah Poling as the first-ever thimerosal “test case” in so-called Vaccine Court, has just been found with many of the same unusual metabolic markers as… you guessed it, Hannah Poling.
Hannah’s case was scheduled to be heard in Federal Claims Court on May 12 -- as one of three “test cases” of the theory that thimerosal (a mercury-based vaccine preservative)
Read the full article only on www.spectrumpublications.com.
About David Kirby
David Kirby is author of the critically acclaimed book “Evidence of Harm, Mercury in Vaccines and the Autism Epidemic – A Medical Controversy”
Kirby, a regular contributor to the Huffington Post, has been a professional journalist for over 15 years, including extensive contributions to The New York Times. He was a foreign correspondent in Mexico and Central America from 1986-1990. Kirby has also worked in politics, medical research and public relations. He lives in Brooklyn, NY.
